These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31548152)

  • 1. Influence of 4 preservation solutions on ICU stay, graft and patient survival following liver transplantation.
    Savier E; Brustia R; Golmard JL; Scatton O;
    J Visc Surg; 2020 Apr; 157(2):87-97. PubMed ID: 31548152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compared efficacy of preservation solutions on the outcome of liver transplantation: Meta-analysis.
    Szilágyi ÁL; Mátrai P; Hegyi P; Tuboly E; Pécz D; Garami A; Solymár M; Pétervári E; Balaskó M; Veres G; Czopf L; Wobbe B; Szabó D; Wagner J; Hartmann P
    World J Gastroenterol; 2018 Apr; 24(16):1812-1824. PubMed ID: 29713134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry.
    Adam R; Delvart V; Karam V; Ducerf C; Navarro F; Letoublon C; Belghiti J; Pezet D; Castaing D; Le Treut YP; Gugenheim J; Bachellier P; Pirenne J; Muiesan P;
    Am J Transplant; 2015 Feb; 15(2):395-406. PubMed ID: 25612492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative prospective study of two available solutions for kidney and liver preservation.
    Pedotti P; Cardillo M; Rigotti P; Gerunda G; Merenda R; Cillo U; Zanus G; Baccarani U; Berardinelli ML; Boschiero L; Caccamo L; Calconi G; Chiaramonte S; Dal Canton A; De Carlis L; Di Carlo V; Donati D; Montanaro D; Pulvirenti A; Remuzzi G; Sandrini S; Valente U; Scalamogna M
    Transplantation; 2004 May; 77(10):1540-5. PubMed ID: 15239618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Celsior and University of Wisconsin solutions in cold preservation of liver from octogenarian donors.
    Nardo B; Beltempo P; Bertelli R; Montalti R; Vivarelli M; Urbani L; Masetti M; Di Naro A; Filipponi F; Mosca F; Pinna A; Cavallari A
    Transplant Proc; 2004 Apr; 36(3):523-4. PubMed ID: 15110579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation.
    Cavallari A; Cillo U; Nardo B; Filipponi F; Gringeri E; Montalti R; Vistoli F; D'amico F; Faenza A; Mosca F; Vitale A; D'amico D
    Liver Transpl; 2003 Aug; 9(8):814-21. PubMed ID: 12884193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celsior versus University of Wisconsin preserving solutions for liver transplantation: postreperfusion syndrome and outcome of a 5-year prospective randomized controlled study.
    García-Gil FA; Serrano MT; Fuentes-Broto L; Arenas J; García JJ; Güemes A; Bernal V; Campillo A; Sostres C; Araiz JJ; Royo P; Simón MA
    World J Surg; 2011 Jul; 35(7):1598-607. PubMed ID: 21487851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Celsior preservation fluid in liver transplantation: one-year follow up of a prospective, multicenter, non-randomized study.
    Boudjema K; Grandadam S; Compagnon P; Salamé E; Wolf P; Ducerf C; Le Treut P; Soubrane O; Cherqui D; Mouchel C; Renault A; Bellissant E
    Clin Transplant; 2012; 26(2):199-207. PubMed ID: 21517997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in adult liver transplantation.
    Rayya F; Harms J; Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):891-4. PubMed ID: 18555073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative impact on islet isolation and transplant outcome of the preservation solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior.
    Niclauss N; Wojtusciszyn A; Morel P; Demuylder-Mischler S; Brault C; Parnaud G; Ris F; Bosco D; Badet L; Benhamou PY; Berney T
    Transplantation; 2012 Apr; 93(7):703-8. PubMed ID: 22343333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreas preservation with University of Wisconsin and Celsior solutions.
    Boggi U; Coletti L; Vistoli F; Del Chiaro M; Signori S; Croce C; Bartolo TV; Pietrabissa A; Marchetti P; Capocasale E; Dalla Valle R; Mazzoni MP; Mosca F
    Transplant Proc; 2004 Apr; 36(3):563-5. PubMed ID: 15110594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celsior solution compared with University of Wisconsin solution (UW) and histidine-tryptophan-ketoglutarate solution (HTK) in the protection of human hepatocytes against ischemia-reperfusion injury.
    Janssen H; Janssen PH; Broelsch CE
    Transpl Int; 2003 Jul; 16(7):515-22. PubMed ID: 12698241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of organ preservation solutions on short-term outcomes after liver transplantation: a single-center retrospective study.
    Van den Eynde J; Achtergaele J; Fieuws S; Jochmans I; Sainz-Barriga M; Monbaliu D; Pirenne J; Gilbo N
    Transpl Int; 2021 Feb; 34(2):327-338. PubMed ID: 33280170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation solutions for static cold storage of abdominal allografts: which is best?
    Parsons RF; Guarrera JV
    Curr Opin Organ Transplant; 2014 Apr; 19(2):100-7. PubMed ID: 24553501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior.
    Straatsburg IH; Abrahamse SL; Song SW; Hartman RJ; Van Gulik TM
    Transplantation; 2002 Aug; 74(4):458-64. PubMed ID: 12352902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UW is superior to Celsior and HTK in the protection of human liver endothelial cells against preservation injury.
    Janssen H; Janssen PH; Broelsch CE
    Liver Transpl; 2004 Dec; 10(12):1514-23. PubMed ID: 15558836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study.
    Boggi U; Vistoli F; Del Chiaro M; Signori S; Croce C; Pietrabissa A; Berchiolli R; Marchetti P; Del Prato S; Mosca F
    Transplantation; 2004 Apr; 77(8):1186-90. PubMed ID: 15114082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Outcomes using two preservation solutions (UW/HTK) in liver transplantation from brain death donors].
    Martínez J; Bächler JP; Moisan F; Torres J; Duarte I; Pérez RM; Benítez C; Arrese M; Domínguez P; Guerra JF; Jarufe N
    Rev Med Chil; 2014 Oct; 142(10):1229-37. PubMed ID: 25601106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable outcome of liver transplantation with histidine-tryptophan-ketoglutarate vs. University of Wisconsin preservation solution: a retrospective observational double-center trial.
    Kaltenborn A; Gwiasda J; Amelung V; Krauth C; Lehner F; Braun F; Klempnauer J; Reichert B; Schrem H
    BMC Gastroenterol; 2014 Sep; 14():169. PubMed ID: 25263587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China.
    Xu X; Zhu YF; Lv T; Zheng JL; Li YK; Zhang BH; Jiang L; Yang JY
    Medicine (Baltimore); 2020 Dec; 99(51):e23584. PubMed ID: 33371088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.